MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice

Antisense oligonucleotide (AO)‐mediated exon‐skipping therapies show promise in Duchenne muscular dystrophy (DMD), a devastating muscular disease caused by frame‐disrupting mutations in the DMD gene. However, insufficient systemic delivery remains a hurdle to clinical deployment. Here, we demonstrat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:EMBO Mol Med
Hoofdauteurs: Ran, Ning, Lin, Caorui, Leng, Ling, Han, Gang, Geng, Mengyuan, Wu, Yingjie, Bittner, Scott, Moulton, Hong M, Yin, HaiFang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863382/
https://ncbi.nlm.nih.gov/pubmed/33337582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012993
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items